Investor Presentaiton
Investment Thesis
✓ Low cost of cultivation¹, debunking claims indoor high quality production = high cost
✓ Sales in all 10 provinces with estimated YTD national market share of 10% in adult-use recreational
market
✓ Strong execution reflected in fiscal 2019 operating and financial results
✓ Positioned well for Rec 2.0 -edibles and derivative products launch: product portfolio initially focused
on 2 most popular form factors, vape pens and edibles
✓ Invested in biosynthesis to produce cannabinoids at a fraction of traditional cultivation costs
✓ Attractive market valuation relative to Canadian LP peers
✓ Disciplined capital allocation focused on maximizing return on investment for shareholders
1
Cost of cultivation per gram is a non-IFRS measure. See the final slides in this presentation
17
2
Based on the Company's analysis of available data including, but not limited to, market share data from select provinces and various public data
ORGANIGRAMView entire presentation